A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon

NCT01285271 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Xenon
Sevoflurane
Anesthetics, Inhalation
Coronary Disease
Coronary Artery Bypass

Interventions

DRUG: Xenon
DRUG: Sevoflurane

Sponsor

RWTH Aachen University

Collaborators

[object Object]